Neurotrophic keratitis is a relatively rare disease that can be difficult to manage, and treatment varies depending on disease stage. In recent years, the development of Oxervate (cenegermin-bkbj ...

Chang: Given its degenerative nature, the conventional treatment challenge has primarily been that neurotrophic keratitis patients are likely to relapse with recurring episodes.

For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated with increased scar size, according to a study ...

Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups ...

The amniotic membrane market is experiencing notable expansion, fueled by several contributing factors. The growing incidence of chronic wounds, including burns and traumatic injuries, is driving the ...

If you want to smooth out your keratosis pilaris bumps, we’ve got you covered. Check out our recommendations for the best treatments to fight keratosis pilaris.